TrialCancer immunology, immunotherapy : CII2020

Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients.

Alessandra Battaglia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.